Expert Consensus on Prevention and Treatment of COVID-19 Infection in Patients with Lung Cancer
10.3779/j.issn.1009-3419.2023.102.12
- Author:
Non-small Cell Lung Cancer Expert Committee of Chinese Society of Clinical Oncology China Medical Education Association
- Keywords:
Corona virus disease 2019;
Lung neoplasms;
Prevention;
Treatment;
Expert consensus
- From:
Chinese Journal of Lung Cancer
2023;26(3):165-176
- CountryChina
- Language:Chinese
-
Abstract:
Corona virus disease 2019(COVID-19)infection has become a major public health issue affecting human health.The main goal of epidemic prevention and control at the current stage in China is to"protect people's health and prevent severe cases".Patients with lung cancer who receive antitumor therapy have low immunity,and the risk of severe illness and death once infected is much higher than healthy people,so they are vulnerable to COVID-19 infection.At present,less attention has been paid to the prevention and treatment of COVID-19 infection in patients with lung cancer in domestic guidelines and consensus.Based on the published data in China and abroad,we proposed recommendations and formed expert consensus on the vaccination of COVID-19,the use of neutralizing antibodies and small molecule antiviral drugs for patients with lung cancer,for physician's reference.
